Director Share Purchases

RNS Number : 6415T

Advanced Medical Solutions Grp PLC

10 June 2009

 



For immediate release

10 June 2009

Advanced Medical Solutions Group PLC 

('AMS' or the 'Company')

Director Share Purchases

Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, announces that the following Directors purchased ordinary shares of 5 pence each ('Ordinary Shares') on 9 June 2009.  

Director	Shares purchased	Purchase price (p)	Resultant holding	% of issued share capital
Don Evans, Chief Executive Officer	20,000	25.5	869,591	0.60
Mary Tavener, Finance Director	25,000	25.5	246,130	0.17
Steve Harris, Non-executive Director	79,270	25.0	202,127	0.14

For further information, please contact:

Advanced Medical Solutions Group plc Don Evans, Chief Executive Officer Mary Tavener, Finance Director www.admedsol.com	Tel: [phone]
Buchanan Communications Mark Court  Stasa Filiplic	Tel: [phone]
Investec Bank plc Richard Jones Tim Pratelli	Tel: [phone]

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.  

The advanced woundcare products are based on the moist wound healing principle. AMS uses its inhouse technology to provide a vertically integrated 'one stop shop' for all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of a 49.4% stake in Corpura BV in May 2008 strengthened AMS's position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market.

AMS' technology in cyanoacrylate based tissue adhesives is used for the closure of small cuts and trauma wounds through to large surgical incisions, and also for protecting or sealing skin to prevent breakdown or infection. 

AMS' products which currently serve the majority of the key global markets are sold either direct or through strategic partners and distributors. 

 

END

 

 

RDSIFFILRAIAIIA